Stephen Machatha, Chief Development Officer: Aldeyra Therapeutics ALDX Sell · Filed 24/03/12

Trade details

Type: Insider sale
Amount: $36,456.92
Shares · price: 11,537 sh · $3.16 a share
Held after: 243,495 sh
Stock: Aldeyra Therapeutics ALDX
Person: Stephen MachathaChief Development Officer
Trade date: 24/03/12
Filed: 24/03/12
Days to filing: 0 days

Sold 4.5% of holdings

Share of holding sold: 4.5%

Aldeyra Therapeutics trades, last 26 weeks

What else happened in Aldeyra Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/11~24/04/11

Stephen Machatha's recent trades

Stephen MachathaChief Development Officer
SellAldeyra Therapeutics
Sell
Aldeyra Therapeutics
ALDX
$113.7K
22,073 sh
$113.7K
Filed 25/08/13
Traded 25/08/11
Stephen MachathaChief Development Officer
Planned saleAldeyra Therapeutics
Planned sale
Aldeyra Therapeutics
ALDX
$116.1K
22,074 sh
$116.1K
Filed 25/08/12
Traded 25/08/12
Stephen MachathaChief Development Officer
SellAldeyra Therapeutics
Sell
Aldeyra Therapeutics
ALDX
$76K
16,041 sh
$76K
Filed 24/08/14
Traded 24/08/12
Stephen MachathaChief Development Officer
SellAldeyra Therapeutics
Sell
Aldeyra Therapeutics
ALDX
$36.5K
11,537 sh
$36.5K
Filed 24/04/17
Traded 24/03/12
Stephen MachathaChief Development Officer
SellAldeyra Therapeutics
Sell
Aldeyra Therapeutics
ALDX
$62.2K
18,231 sh
$62.2K
Filed 24/03/12
Traded 24/03/11

Stephen Machatha, Chief Officer — sold $36.5K of Aldeyra Therapeutics ALDX · 4.5% of holdings | Whalegun